celastrol has been researched along with cyclin d1 in 2 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, YL; Wang, Y; Yang, FL; Yi, H; Zhang, Y | 1 |
| Jang, SW; Jang, SY; Ko, J | 1 |
2 other study(ies) available for celastrol and cyclin d1
| Article | Year |
|---|---|
[Celastrol down-regulates expression of P-Akt and cyclin D1 in HL-60 cells and induces apoptosis].
Topics: Apoptosis; Cyclin D1; Down-Regulation; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-akt; Triterpenes | 2010 |
Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cyclin D1; Cytoplasm; Estrogen Receptor alpha; Female; Humans; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-myb; Receptors, Estrogen; RNA, Messenger; Triterpenes | 2011 |